Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cyclerion Therapeutics Q2 EPS $(0.11) Up From $(0.53) YoY, Sales $96.00K

Author: Benzinga Newsdesk | August 05, 2025 03:48pm
Cyclerion Therapeutics (NASDAQ:CYCN) reported quarterly losses of $(0.11) per share. This is a 79.25 percent increase over losses of $(0.53) per share from the same period last year. The company reported $96.00 thousand in sales this quarter.

Posted In: CYCN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist